Suntrust Banks Inc. grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 6.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,484 shares of the medical instruments supplier’s stock after acquiring an additional 1,334 shares during the period. Suntrust Banks Inc.’s holdings in DENTSPLY SIRONA were worth $1,392,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the business. Commonwealth Bank of Australia lifted its stake in shares of DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the period. Acrospire Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $113,000. Dupont Capital Management Corp bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $116,000. Korea Investment CORP boosted its position in shares of DENTSPLY SIRONA by 139.9% during the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after purchasing an additional 1,251 shares in the last quarter. Finally, Sphera Funds Management LTD. bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $162,000. Hedge funds and other institutional investors own 93.87% of the company’s stock.

Several research firms recently commented on XRAY. BidaskClub cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Wednesday, July 19th. Credit Suisse Group reissued an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research note on Thursday, July 13th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target on the stock. Finally, Morgan Stanley increased their price target on DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a report on Thursday, August 10th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $65.80.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at 56.33 on Tuesday. The firm has a 50-day moving average price of $56.77 and a 200-day moving average price of $61.39. DENTSPLY SIRONA Inc. has a 52 week low of $52.54 and a 52 week high of $65.68. The firm’s market cap is $12.93 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million for the quarter, compared to analysts’ expectations of $1 billion. During the same quarter in the previous year, the company earned $0.76 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-holdings-increased-by-suntrust-banks-inc/1605139.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.